ENGINEERING MEDICINES TO IMPROVE PATIENT CARE

Investors

SEC Filing Details

Document Details

Form
Filing Date
November 12, 2013
Document Date
November 12, 2013
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Viridian Therapeutics Inc.
Issuer
VIRIDIAN THERAPEUTICS, INC.\DE